Oppenheimer & Co. Inc. Sells 4,850 Shares of SPDR S&P Biotech ETF $XBI

Oppenheimer & Co. Inc. decreased its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 7.3% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 61,926 shares of the exchange traded fund’s stock after selling 4,850 shares during the period. Oppenheimer & Co. Inc. owned about 0.10% of SPDR S&P Biotech ETF worth $6,205,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently bought and sold shares of the company. AQR Capital Management LLC increased its holdings in shares of SPDR S&P Biotech ETF by 77.1% in the 1st quarter. AQR Capital Management LLC now owns 4,978 shares of the exchange traded fund’s stock valued at $404,000 after acquiring an additional 2,167 shares during the period. IFP Advisors Inc grew its stake in SPDR S&P Biotech ETF by 22.8% in the second quarter. IFP Advisors Inc now owns 3,909 shares of the exchange traded fund’s stock valued at $324,000 after purchasing an additional 727 shares during the last quarter. RFG Advisory LLC purchased a new position in SPDR S&P Biotech ETF in the second quarter valued at about $208,000. 5th Street Advisors LLC raised its holdings in SPDR S&P Biotech ETF by 5.1% in the second quarter. 5th Street Advisors LLC now owns 18,072 shares of the exchange traded fund’s stock worth $1,499,000 after purchasing an additional 882 shares in the last quarter. Finally, Activest Wealth Management lifted its position in shares of SPDR S&P Biotech ETF by 647.0% during the second quarter. Activest Wealth Management now owns 874 shares of the exchange traded fund’s stock valued at $72,000 after buying an additional 757 shares during the last quarter.

SPDR S&P Biotech ETF Stock Performance

NYSEARCA:XBI opened at $125.34 on Wednesday. The company’s 50-day simple moving average is $124.37 and its 200-day simple moving average is $109.28. SPDR S&P Biotech ETF has a fifty-two week low of $66.66 and a fifty-two week high of $132.09. The stock has a market capitalization of $8.38 billion, a P/E ratio of 11.47 and a beta of 0.93.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.